Search
Selected Filter
Displaying 91–100 of 508 news results
-
Research News
The five-year grant will advance the emerging treatments toward clinical trials
-
Beacon Therapeutics to Advance XLRP, Cone-Rod Dystrophy, and Dry AMD Gene Therapies
Research NewsAn emerging XLRP gene therapy acquired from AGTC is the company’s lead clinical program
-
Coave Reports Encouraging Phase 1/2 Clinical Trial Results for PDE6B Gene Therapy
Research NewsThe company is expanding the trial to enroll younger patients with less advanced disease
-
Summary of the Eighth Annual Retinal Cell & Gene Therapy Innovation Summit 2023
Research NewsThe Retinal Cell and Gene Therapy Innovation Summit has emerged as one of the most essential events for researchers and companies developing treatments and cures for retinal degenerative diseases. In its eighth year, the Innovation Summit featured 30 presentations from retina experts from around the world with more than 300 people in attendance.
-
Atsena Receives FDA Authorization to Launch a Gene Therapy Clinical Trial for XLRS
Research NewsKnown as The Lighthouse Study, the Phase ½ trial is expected to begin in mid-2023
-
Foundation Fighting Blindness and Athletes for Hope Announce Strategic Partnership
Foundation NewsThis partnership will drive awareness for blinding diseases throughout the athletic community.
-
Eric Pierce Receives Proctor Medal for Outstanding Achievements in Retinal Research
Research NewsDuring his Proctor Award Lecture, Dr. Pierce reviewed encouraging clinical trial results for Editas’ CRISPR/Cas9 treatment for people with LCA10
-
Research News
Dr. Tucker is leading the development of GMP facilities for manufacturing clinical grade retinal therapies
-
Foundation News
The May 11th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
Statement from Jason Menzo about Lyft's Refusal to Accept Rider with Guide Dog.
Foundation NewsAs CEO of an organization committed to those impacted by vision loss, it is disheartening there is still discrimination against visually impaired riders who use ride-sharing apps like Uber and Lyft.
